Estevinho, F <br/><br/>
Treatment of advanced EGFR-mutant NSCLC patients: Sequencing matters.  [electronic resource] 

 -  Pulmonology   
 - 306-309 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>2531-0437 
<br/><br/><label>Standard No.: </label>10.1016/j.pulmoe.2019.04.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Clinical Trials, Phase III as Topic<br/>DNA Mutational Analysis<br/>ErbB Receptors--genetics<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Mutation<br/>Protein Kinase Inhibitors--therapeutic use